Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹6.31 Cr₹29 Cr₹4.30 Cr₹5.84 Cr₹19 Cr

What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH is ₹6.31 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹6.31 Cr
Mar2023₹29 Cr
Mar2022₹4.30 Cr
Mar2021₹5.84 Cr
Mar2020₹19 Cr

How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹6.31 Cr
-78.32
Mar2023 ₹29 Cr
577.69
Mar2022 ₹4.30 Cr
-26.39
Mar2021 ₹5.84 Cr
-69.37
Mar2020 ₹19 Cr -

Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹592.5 Cr -10.8% -1.9% -2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-10.8%

-1.9%

-2.8%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses